ETHAMOLIN (ethanolamine oleate)
VENOSCLEROSING AGENTS · BLEEDING ESOPHAGEAL VARICES
QOL MEDICAL
Drug class
Venosclerosing Agents
Venosclerosing agents are a specialized therapeutic class of injectable sclerosants designed to chemically ablate diseased or malfunctioning veins. Read more about Venosclerosing Agents
5 drugs in this class 5 manufacturers
Drugs in Venosclerosing Agents
SOTRADECOL (sodium tetradecyl sulfate)
VENOSCLEROSING AGENTS · VARICOSE VEINS
MYLAN INSTITUTI
ASCLERA (polidocanol)
VENOSCLEROSING AGENTS · VARICOSE VEINS
METHAPHARM INC
VARITHENA (polidocanol)
VENOSCLEROSING AGENTS · VARICOSE VEINS
BIOCOMPATIBLES/
SODIUM TETRADECYL SULFATE
VENOSCLEROSING AGENTS · VARICOSE VEINS
LEUCADIA/HIKMA
Filter & compare in the drug finder →
Opens the drug finder with Venosclerosing Agents preselected. Add indication or manufacturer filters there.
Venosclerosing agents are a specialized therapeutic class of injectable sclerosants designed to chemically ablate diseased or malfunctioning veins.
Administered directly into the target vessel lumen—often as a liquid solution or microfoam—these agents disrupt the vascular endothelial lining, exposing subendothelial collagen and triggering a controlled local inflammatory cascade that results in endovascular thrombosis, vessel collapse, and permanent fibrotic occlusion.
Their primary therapeutic role is in phlebology and vascular medicine, where they are widely utilized to manage chronic venous insufficiency, treat incompetent saphenous veins and varicosities, and eliminate spider or reticular veins.
Common clinical examples in this class include polidocanol and sodium tetradecyl sulfate.
-
fda.gov
Venosclerosing agents are a specialized therapeutic class of injectable sclerosants designed to chemically ablate diseased or malfunctioning veins Administered directly into the target vessel lumen—often as a liquid solution or microfoam—these agents disrupt the vascular endothelial lining, exposing subendothelial collagen and triggering a controlled local inflammatory cascade that results in endovascular thrombosis, vessel collapse, and permanent fibrotic occlusion Their primary therapeutic rol...
-
nih.gov
Venosclerosing agents are a specialized therapeutic class of injectable sclerosants designed to chemically ablate diseased or malfunctioning veins Administered directly into the target vessel lumen—often as a liquid solution or microfoam—these agents disrupt the vascular endothelial lining, exposing subendothelial collagen and triggering a controlled local inflammatory cascade that results in endovascular thrombosis, vessel collapse, and permanent fibrotic occlusion Common clinical examples in t...
-
fda.gov
Administered directly into the target vessel lumen—often as a liquid solution or microfoam—these agents disrupt the vascular endothelial lining, exposing subendothelial collagen and triggering a controlled local inflammatory cascade that results in endovascular thrombosis, vessel collapse, and permanent fibrotic occlusion
-
fda.gov
Their primary therapeutic role is in phlebology and vascular medicine, where they are widely utilized to manage chronic venous insufficiency, treat incompetent saphenous veins and varicosities, and eliminate spider or reticular veins Common clinical examples in this class include polidocanol and sodium tetradecyl sulfate
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.